Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • Wei-HD
    Member
    • Oct 2009
    • 59

    #1

    Cuffcompare Result help

    Dear all,

    I just run cuffcompare -r [reference.GTF] [transcript.GTF], the output file included the transcripts.tmap which showed gene names and FPKM info. Following is one of the genes:

    Bdnf ENSMUST00000053317 = CUFF.114250 CUFF.114250.1 97 32.073177 28.162251 35.984103 35.033306 1633 CUFF.114250.1
    Bdnf ENSMUST00000111050 = CUFF.114251 CUFF.114251.2 100 33.063804 27.584704 38.542903 36.115361 1249 CUFF.114250.1
    Bdnf ENSMUST00000111052 = CUFF.114252 CUFF.114252.3 62 20.483324 14.448689 26.517959 22.373791 1105 CUFF.114250.1
    Bdnf ENSMUST00000111047 c CUFF.114254 CUFF.114254.1 100 10.649808 7.099872 14.199745 11.639716 235 CUFF.114254.1
    Bdnf ENSMUST00000111042 c CUFF.114256 CUFF.114256.1 100 23.582192 21.902030 25.262353 25.777043 2323 CUFF.114256.1
    Bdnf ENSMUST00000053317 p CUFF.114258 CUFF.114258.1 100 0.557202 0.000000 1.467470 0.609143 187 CUFF.114258.1

    I am a bit confused with the result, since I have done qPCR experiment of BDNF gene, and it will be upregulated like 5-6 folds compared with control. I only run with the treated sample and the reference GTF file, so the FPKM value is not the like fold change, right? also the class code, should I only trust "="? and what does "p" and "i" mean? If I only use "=" FPKM value, how can I extract the one with the class code "="?

    And if I run cuffcompare -r [reference.GTF] [treated.GTF] [control.GTF], how could I get the fold changes (treated/control)?

    Sorry for such naive questions? Can someone kindly explain to me?

    With many thanks in advance!!

    Wei

Latest Articles

Collapse

  • SEQadmin2
    Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
    by SEQadmin2



    Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

    Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
    ...
    10-14-2026, 09:55 AM
  • SEQadmin2
    New Genomics Technologies Take Aim at Long-Standing Limits
    by SEQadmin2


    Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

    We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
    ...
    09-28-2026, 10:25 AM

ad_right_rmr

Collapse

News

Collapse

Topics Statistics Last Post
Started by SEQadmin2, 10-22-2026, 11:13 AM
0 responses
27 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-22-2026, 10:48 AM
0 responses
20 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-15-2026, 10:52 AM
0 responses
36 views
0 reactions
Last Post SEQadmin2  
Started by SEQadmin2, 10-14-2026, 05:39 AM
0 responses
43 views
0 reactions
Last Post SEQadmin2  
Working...